ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder
The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑158 for ASCENT‑IBO: Accelerating Safe Clinical Evaluation of Novel Treatments – Ibogaine for Better Outcomes in OUD. This effort sits under the Proactive Health Office (PHO) Innovative Solutions Opening (ISO ARPA‑H‑SOL‑24‑106) and is directly tied to Executive Order 14401, which directs federal agencies […]
ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder Read More »












